Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

457

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

"Treat-to-target (individually adjusted dose) titration according to titration algorithm.~S.c. (under the skin) injection once daily as an add-on to subjects' stable pre-trial metformin dose (at least 1500 mg/day). Any other use of OAD will be discontinued"

DRUG

insulin glargine

"Treat-to-target (individually adjusted dose) titration according to titration algorithm.~S.c. (under the skin) injection once daily as an add-on to subjects' stable pre-trial metformin dose (at least 1500 mg/day). Any other use of OAD will be discontinued"

Trial Locations (88)

1405

Novo Nordisk Investigational Site, Capital Federal

1429

Novo Nordisk Investigational Site, Capital Federal

10110

Novo Nordisk Investigational Site, Bangkok

10301

Novo Nordisk Investigational Site, Staten Island

10330

Novo Nordisk Investigational Site, Bangkok

10400

Novo Nordisk Investigational Site, Bangkok

11768

Novo Nordisk Investigational Site, Northport

12120

Novo Nordisk Investigational Site, Pathum Thani

13210

Novo Nordisk Investigational Site, Syracuse

16214

Novo Nordisk Investigational Site, Clarion

16602

Novo Nordisk Investigational Site, Altoona

17601

Novo Nordisk Investigational Site, Lancaster

19104

Novo Nordisk Investigational Site, Philadelphia

19107

Novo Nordisk Investigational Site, Philadelphia

19401

Novo Nordisk Investigational Site, Norristown

20852

Novo Nordisk Investigational Site, Rockville

23462

Novo Nordisk Investigational Site, Virginia Beach

25401

Novo Nordisk Investigational Site, Martinsburg

27103

Novo Nordisk Investigational Site, Winston-Salem

27408

Novo Nordisk Investigational Site, Greensboro

28277

Novo Nordisk Investigational Site, Charlotte

29303

Novo Nordisk Investigational Site, Spartanburg

29651

Novo Nordisk Investigational Site, Greer

29687

Novo Nordisk Investigational Site, Taylors

30076

Novo Nordisk Investigational Site, Roswell

30127

Novo Nordisk Investigational Site, Powder Springs

32081

Novo Nordisk Investigational Site, Ponte Vedra

32204

Novo Nordisk Investigational Site, Jacksonville

32207

Novo Nordisk Investigational Site, Jacksonville

32804

Novo Nordisk Investigational Site, Orlando

33021

Novo Nordisk Investigational Site, Hollywood

33136

Novo Nordisk Investigational Site, Miami

33143

Novo Nordisk Investigational Site, Miami

33324

Novo Nordisk Investigational Site, Plantation

33880

Novo Nordisk Investigational Site, Winter Haven

34471

Novo Nordisk Investigational Site, Ocala

37404

Novo Nordisk Investigational Site, Chattanooga

37411

Novo Nordisk Investigational Site, Chattanooga

44223

Novo Nordisk Investigational Site, Cayahoga Falls

45245

Novo Nordisk Investigational Site, Cincinnati

45406

Novo Nordisk Investigational Site, Dayton

49620

Novo Nordisk Investigational Site, Buckley

53209

Novo Nordisk Investigational Site, Milwaukee

59701

Novo Nordisk Investigational Site, Butte

63017

Novo Nordisk Investigational Site, Chesterfield

63141

Novo Nordisk Investigational Site, St Louis

65109

Novo Nordisk Investigational Site, Jefferson City

66204

Novo Nordisk Investigational Site, Shawnee Mission

72143

Novo Nordisk Investigational Site, Searcy

74104

Novo Nordisk Investigational Site, Tulsa

75230

Novo Nordisk Investigational Site, Dallas

75246

Novo Nordisk Investigational Site, Dallas

76054

Novo Nordisk Investigational Site, Hurst

77025

Novo Nordisk Investigational Site, Houston

78209

Novo Nordisk Investigational Site, San Antonio

78404

Novo Nordisk Investigational Site, Corpus Christi

79761

Novo Nordisk Investigational Site, Odessa

80045

Novo Nordisk Investigational Site, Aurora

84790

Novo Nordisk Investigational Site, St. George

85340

Novo Nordisk Investigational Site, Litchfield Park

90057

Novo Nordisk Investigational Site, Los Angeles

90822

Novo Nordisk Investigational Site, Long Beach

91978

Novo Nordisk Investigational Site, Spring Valley

92025

Novo Nordisk Investigational Site, Escondido

92374

Novo Nordisk Investigational Site, Redlands

92705

Novo Nordisk Investigational Site, Santa Ana

92801

Novo Nordisk Investigational Site, Anaheim

93720

Novo Nordisk Investigational Site, Fresno

94520

Novo Nordisk Investigational Site, Concord

98057

Novo Nordisk Investigational Site, Renton

600028

Novo Nordisk Investigational Site, Chennai

06851

Novo Nordisk Investigational Site, Norwalk

83404-7596

Novo Nordisk Investigational Site, Idaho Falls

67301-3263

Novo Nordisk Investigational Site, Independence

04101

Novo Nordisk Investigational Site, Portland

02453

Novo Nordisk Investigational Site, Waltham

07011

Novo Nordisk Investigational Site, Clilfton

45631-1560

Novo Nordisk Investigational Site, Gallipolis

B1704ETD

Novo Nordisk Investigational Site, Buenos Aires

B7600FZN

Novo Nordisk Investigational Site, Mar del Plata

560 017

Novo Nordisk Investigational Site, Bangalore

695 032

Novo Nordisk Investigational Site, Thriruvananthapuram

00674

Novo Nordisk Investigational Site, Manatí

00976

Novo Nordisk Investigational Site, Trujillo Alto

110-746

Novo Nordisk Investigational Site, Seoul

130-701

Novo Nordisk Investigational Site, Seoul

138-736

Novo Nordisk Investigational Site, Seoul

139-707

Novo Nordisk Investigational Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00909480 - Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter